In present study (5-(5-chloro-1,3-diphenyl-1H-pyrazole-4-yl)-3-(substitutedphenyl)-1H-pyrazol-1-yl)(pyridine-4-yl)methanone (4a-4o)were synthesized by starting with acetophenone and phenylhydrazine resulting in the formation of acetophenonephenylhydrazone(1). Compound (1) on Vilsmeier-Haack reaction yielded 5-chloro-1,3-diphenyl-1H-pyrazole-4-carbaldehyde (2), which on condensation with substituted acetophenone gave substituted arylidenepyrazoles(3a-3o) followed by the reaction with isoniazid yielded the titled compounds (4a-4o). All the newly synthesized pyrazolederivatives were characterized by UV, FTIR, 1 H NMR, MASS spectrometry and elemental analysis. All the newly synthesized derivatives were also evaluated for their antitubercular activity against Mycobacterium tuberclosis H 37 Rv using agar dilution method as well as for anticancer activity against MCF7 (Human breast cancer) cells by SRB assay.
INTRODUCTION
Pyrazole scaffold represent a common motif demonstrating a wide range of pharmacological activities like anticancer [1] [2] , anti-inflammatory 3 , adenosine receptor antagonists [4] [5] , antibacterial 6 , anti-HIV 7 ,antiulcer 8 , antitubercular 9 and antioxidantactivity 10 . Tuberclosis and cancer are diseases which becomes a cause of highest mortality rate worldwide 11 . About one-third world population is suffering from these two diseases.
In search of better anticancer and antitubercular drug, it was thought worthwhile to synthesize a series of pyrazole derivatives. Keeping in view the diverse therapeutic activities of pyrazole containing compounds and as a part of our ongoing development of efficient protocols for preparation of bioactive heterocycles, the present studies describes a simple and novel synthesis of the titled compounds in hope of getting potent biodynamic agents and evaluate their potential for antitubercular and anticancer activities.
EXPERIMENTAL
The purity of all the newly synthesized compounds were checked by TLC on silica gel-coated aluminum sheets (Type 60 F 254 , Merck) and the spots were detected by exposure to iodine vapors and UV-lamp at ë max 254 nm. The melting points were determined in open capillary tube and are uncorrected. The infrared (FTIR) spectra were recorded on 470-Shimadzu Infrared Spectrophotometer using the KBr disc prepared by pressed pellet technique and expressed in cm -1 . 1 H NMR spectra were recorded on Bruker DRX-300 using
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DMSO-d 6 as solvent. The chemical shift was given in ä (ppm) in a downfield manner using tetramethylsilane (TMS) as an internal standard. Elemental analysis was carried on Elemental Vario EL III Carlo Erba 1108 and the values were within permissible limit of ±0.04% of the theoretical values. Mass spectrum was obtained using LC-MS (Shimadzu-2010AT) under Electrospray Ionization (ESI) technique.
SYNTHETIC PROCEDURE Synthesis of Acetophenone phenyl hydrazone (1)
A mixture of acetophenone (0.167 moles, 20.04 gm) and Phenyl hydrazine (0.167 moles, 18.00 gm) in 60 ml of ethanol with few drops of glacial acetic acid was heated for 9 hrs between 50-60°C. Then it was cooled, filtered and washed with dilHCl and rectified spirit, the dried solid was recrystallized from ethanol to get offwhite acetophenone phenyl hydrazone (1) (70.6%, m.p. 105-106°C).
Synthesis of 5-chloro-1,3-diphenyl-1H-pyrazole-4-carbaldehyde (2)
Acetophenone phenyl hydrazone(1) (0.004 mole, 0.84gm) was dissolved in 10ml of DMF at 0-5°C with continuous stirring. To this solution 1.1 ml of POCl 3 was added drop wise with stirring. Then the reaction mixture was heated on water bath at 50-60°C for 15 hrs and cooled at room temperature.The mixture was poured into crushed ice and neutralized by adding 5% NaHCO 3 solution. The resulting solid was filtered, washed with water and dried. The dried solid was recrystallized with aqueous methanol to get yellow coloured compound (2) (52.5%, m.p.118-119°C).
Synthesis of 3-(5-chloro-1,3-diphenyl-1H-pyrazol-4-yl)-1-(substituted phenyl)prop-2-en-1-one (3a-3o)
To a solution of 5-chloro-1,3-diphenyl-1H-pyrazole-4-carbaldehyde(2) (0.01 mol, 2.82gm) in 10 ml of 10% ethanolic sodium hydroxide solution, substituted acetophenone (0.01mol) was added slowly with vigorous stirring at 25ºC. The completion of reaction was checked by TLC.After completion of reaction the product was filtered, dried and recrystallized from ethanol to obtained 3-(5-chloro-1,3-diphenyl-1H-pyrazol-4-yl)-1-(substituted phenyl)prop-2-en-1-one(3a-3o).
Synthesis of(5-(5-chloro-1,3-diphenyl-1H-pyrazole-4-yl)-3-(substituted phenyl)-1H-pyrazol-1-yl) (pyridine-4-yl) methanone (4a-4o) A mixture of compound (3a-3o)(0.01 moles), Isoniazid (0.02 moles, 2.44 gm) and 2 ml of glacial acetic acid was refluxed for 22-24 hrs. The resulting solution was poured into ice cold water with constant stirring, solid was separated, filtered, dried and recrystallized from suitable solvent to obtained titled compounds (4a-4o).
Spectral data of the synthesized derivatives (4a-4o) 5-chloro-1,3-diphenyl-1H-pyrazole-4-yl)-3-(2-chlorophenyl)-1H-pyrazol-1-yl) (pyridine-4-yl 5-chloro-1,3-diphenyl-1H-pyrazole-4-yl)-3-(3-bromophenyl)-1H-pyrazol-1-yl)(pyridine-4-yl (11) C-H def. 
Pharmacological Screening Antitubercular Activity
The newly synthesized compounds were tested for their antitubercular activity against M. tuberculosis H 37 Rv using agar dilution method 12 .It is a semi-quantitative method for determination of in vitro activity of antitubercular agents, which provides a specific Minimum Inhibitory Concentration (MIC). In dilutions tests, microorganisms were tested for their ability to produce visible growth on series of Middlebrook and Cohn 7H11 agar 13 in quadrant plates containing dilutions of antitubercular agents. DMSO was used as a vehicle and isoniazid was used as standard. All the plates were incubated at 37°C in 5% CO 2 for 4 weeks, after which viable counting was performed. The antitubercular activity exhibited by the compounds is shown in Table- 1.
Anticancer Activity
All the newly synthesized pyrazole derivatives were screened for their anticancer activity against MCF7 (Human breast cancer) cell line by SRB (Sulphorodamine B) assay [14] [15] . Under mild conditions, SRB binds to protein basic amino acid residue in Srivastava Neha et al.
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trichloroacetic acid (TCA) fixed cells to provide sensitive index of cellular protein content that is linear over a cell density. Colour development in SRB assay is rapid, stable and visible. The developed colour can be measured over a broad range of visible wavelength in either a spectrophotometer or a 96 well plate reader. The cell lines were grown in RPMI1640 medium containing 10% foetal bovine serum and 2mM Lglutamine. After cell inoculation, the microtiter plates were incubated at 37° C, 5 % CO 2 , 95 % air and 100 % relative humidity for 24 h prior to addition of experimental drugs. Vehicle used was DMSO and adriamycin was used as standard drug. Drug concentration resulting in 50 % reduction in the net protein in control cells during the drug incubation was calculated. Anticancer activity exhibited by the synthesized compounds is shown in Table-2. 
RESULTS AND DISCUSSION
A series of substituted pyrazole derivatives(4a-4o)was prepared by following the scheme-1. The physical properties like melting point, R f value are shown in Table- In vitroantitubercular screening was done against M. tuberculosis H 37 Rv using agar dilution method. Results (as shown in Table- 1) revealed that compound 4n exhibited promising antitubercular activity with 88% inhibition and found to be most potent. Compounds 4f and 4h exhibited good activity with 75% and 73% inhibition respectively. The other derivatives showed marked antitubercular activity. The electron withdrawing groups on benzene ring at C 3 of the pyrazole moiety showed promising activity compared to others. The selected derivatives evaluated for anticancer activities were 4f, 4g, 4h, 4l and 4n (results as shown in Table-2) . Compounds 4f, 4h and 4n were active on Human Breast Cancer cell line. Compound 4f has minimum GI50value among all the tested compounds and was found to be most potent.Other compounds possessed good activity in compare to the standard drug adriamycin.
